Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) Biotest's fibrinogen aims to fulfill a high unmet medical need for ...

A MATERNITY unit has received additional funding to launch a two-year pilot to help revolutionise care for birthing mothers, ...

Biotest's Fibrinogen Aims to Fulfill a High Unmet Medical Need for Additional Fibrinogen to Treat Acquired Fibrinogen Deficiency US Submission Follows EU Application for Marketing Authorization ...

In February, the company reported positive efficacy results from a trial investigating Grifols’ fibrinogen concentrate (FC), BT524, for the treatment of acquired fibrinogen deficiency (AFD).

Calculated from lab values taken at admission for labor, the fibrinogen-to-albumin ratio (FAR) emerged as an independent ...